Schedule 13D ownership disclosure

MABVAX THERAPEUTICS HOLDINGS, INC.

Security class unavailable · CUSIP: 55414P702

Event date: 2018-01-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001654954-18-002107
Form type
SC 13D/A
Filer
HANSEN JOHN DAVID
CIK
CIK 1186123
Filed
Mar 02, 2018
Reporting period
Jan 16, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub